Medications for Her2positive Carcinoma Of Breast

4 results
  • margenza - margetuximab - cmkb injection, solution, concentrate

    (Margetuximab-Cmkb)
    Macrogenics, Inc
    Margenza is used with chemotherapy to treat adults with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens, with at least one for metastatic disease.
  • nerlynx - neratinib tablet

    (Neratinib)
    Puma Biotechnology, Inc.
    Nerlynx is a kinase inhibitor for adults with HER2-positive breast cancer. Used alone for extended adjuvant treatment of early-stage disease following trastuzumab therapy, or with capecitabine for advanced or metastatic disease after two or more prior anti-HER2 regimens.
  • phesgo - pertuzumab, trastuzumab, and hyaluronidase - zzxf injection, solution

    (Pertuzumab, Trastuzumab, And Hyaluronidase-Zzxf)
    Genentech, Inc.
    Phesgo (pertuzumab, trastuzumab, hyaluronidase) treats HER2-positive breast cancer in adults: neoadjuvant and adjuvant treatment with chemotherapy for early-stage breast cancer, and with docetaxel for metastatic breast cancer in patients who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease.